How McKesson Corporation stacks up

MCK · against 28 other Healthcare companies of similar size

Growth

69/ 100

Near the top of its peers.

Ranked #8 of 29 · scores higher than 75% of peers

Bars: peers in each 10-point band of the growth score

4 peers with a growth score of 60–69, including MCK · Click a bar to see the companies

Why growth scores 69?

Weighted metrics compared with all Healthcare companies.

Mainly thanks to its earnings per share growth and 3-year revenue growth, which are stronger than most Healthcare peers.

Revenue growth is close to the peer norm. Revenue growth: 8.8% vs peer median 6.1%
faster revenue growth over three years: stronger than 70% of peers. 3-year revenue growth: 13.1% vs peer median 5.8%
faster growth in earnings per share: stronger than 78% of peers. Earnings per share growth: 54.8% vs peer median 9.8%

Metric by metric

Position: dot = MCK, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	MCK	Peer median	Better than	Weight
Revenue growthHigher is better · 29 reported	8.8%	7.3%	75%	33%
Earnings per share growthHigher is better · 27 reported	54.8%	22.5%	73%	33%
3-year revenue growthHigher is better · 29 reported	13.1%	5.2%	86%	33%

Ranking by growth score

Top 5 and the companies ranked around MCK

Rank	Company	Market cap	Growth	Overall
1	Medtronic plcMDT · US-listed	126.5B USD	78	56
2	WuXi AppTec Co., Ltd.2359.HK · Hong Kong	534.1B HKD (≈$68.4B)	76	75
3	Boston Scientific CorporationBSX · US-listed	63.0B USD	73	65
3	Intuitive Surgical, Inc.ISRG · US-listed	155.7B USD	73	64
5	GSK plcG1SK34.SA · Brazil	540.4B BRL (≈$97.3B)	72	64
5	GSK plcGSK · US-listed	97.5B USD	72	67
5	GSK plcGSK.BA · Latin America	162.93T ARS (≈$162.9B)	72	63

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score